Patient P-02109
Synthetic patientMETA-24 · Day 171 · 25–34 · M · baseline S04Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Stable
Discontinuation risk
22%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S04
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Treatment adherence-6
- Nutritional resilience-4
- GI instability+2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable64 min
worsening · -6.7 vs previous 14 d
Sleep duration
Wearable7.1 h
stable · +0.1 vs previous 14 d
Energy level
Daily log6/10
improving · +0.2 vs previous 14 d
Steps
Wearable7,516
worsening · -495 vs previous 14 d
GI burden
Companion24.9/100
improving · -2.6 vs previous 14 d
Adherence
Companion87.7 %
stable · -1.9 vs previous 14 d
Sleep quality
Wearable46.8/100
stable · +0.9 vs previous 14 d
Glucose, CGM daily mean
CGM132 mg/dL
stable · -2.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 72 from the failing basin, 15 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Protein (supports)perturbation · steering +7
- Proteinsupporter · GI -3.6 next day
Main detractors to watch
- Bacteroides fragilis elevatedhidden · steering -7.4
- Poor-sleep weekperturbation · steering -3
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.6supporter · 95%
- Ultra-processed food-0.9no signal · 26%
- Histamine load-0.8no signal · 24%
- Dietary fat load-0.6no signal · 15%
- Insoluble fibre-0.3no signal · 15%
- Caffeine+0.3no signal · 15%
- Alcohol+0.1no signal · 15%
- Simple carbohydrates0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 34 ms, trending down
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3 · butyrate capacity 81/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 35 ms
- Sleep
- 7.1 h
- Steps
- 6,545
- Resting HR
- 70 bpm
Daily log: GI score 25, nutritional resilience 59, adherence 88.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02483 | 45% | S06 | BR-03 | no change | 64 |
| P-02267 | 35% | S09 | BR-03 | no change | 45 |
| P-02280 | 34% | S07 | BR-03 | no change | 50 |
| P-02354 | 43% | S01 | CR-01 | improved | 78 |
| P-02518 | 53% | S17 | DT-01 | improved | 68 |
| P-02491 | 51% | S09 | DT-01 | no change | 65 |
| P-02462 | 44% | S12 | DT-01 | improved | 65 |
| P-02126 | 41% | S16 | DT-01 | improved | 59 |
| P-02235 | 38% | S14 | DT-01 | improved | 50 |
| P-02274 | 38% | S15 | DT-01 | improved | 50 |
| P-02330 | 38% | S15 | DT-01 | no change | 57 |
| P-02339 | 38% | S03 | DT-01 | improved | 50 |